Background Local treatment (metastasectomy or stereotactic radiotherapy) for
oligometastatic disease (OMD) in patients with esophagogastric cancer may improve overall …

Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …

Simple Summary Oligometastatic prostate cancer has classically been defined as a small
volume of prostate cancer spread as defined by imaging using CT, MRI, and bone scans …

Background Long-term outcomes of patients treated with salvage lymph node dissection
(sLND) for nodal recurrence of prostate cancer (PCa) remain unknown. Objective To …

Background Consensus about the definition and treatment of oligometastatic
oesophagogastric cancer is lacking. Objective To assess the definition and treatment of …

Background Local treatment improves the outcomes for oligometastatic disease (OMD, ie an
intermediate state between locoregional and widespread disseminated disease). However …

Background In contrast to other cancers, the concept of oligometastatic disease (OMD) has
not been investigated in bladder cancer (BC). Objective To develop an acceptable definition …

Background Although renal cell carcinoma (RCC) is believed to have a strong hereditary
component, there is a paucity of published guidelines for genetic risk assessment. A panel of …

Background In recent years, there is increasing evidence showing a beneficial outcome (eg
progression free survival; PFS) after metastases-directed therapy (MDT) with external beam …

Since its introduction to the diagnostic pathway for prostate cancer management, prostate-
specific membrane antigen (PSMA)–ligand PET has demonstrated great potential. PSMA …